Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …

Antipsychotics are the first-line treatment for people with schizophrenia or psychosis. There
is evidence that they can reduce the symptoms of psychosis and risk of relapse. However …

Is depression simply the result of chemical imbalances, or Schizophrenia a wholly biological
disorder? What role do the broader circumstances of an individual's social, cultural and …

Background Antipsychotic drugs are usually the first line of treatment for schizophrenia;
however, many patients refuse or discontinue their pharmacological treatment. We aimed to …

Embodied Selves and Divided Minds examines how research in embodied cognition and
enactivism can contribute to our understanding of the nature of self-consciousness, the …

Evidence regarding overestimation of the efficacy of antipsychotics and underestimation of
their toxicity, as well as emerging data regarding alternative treatment options, suggests it …

Depression is common in people with schizophrenia, but how it might directly contribute to
the persistence of psychotic symptoms has rarely been tested. The key aim of the present …

In the past two decades there has been a change of emphasis in research on
psychopathology. Investigators have now begun to focus on specific psychological …

Antipsychotic medication represents the treatment of choice in psychosis according to
clinical guidelines. Nevertheless, studies show that half to almost three-quarter of all patients …

Objective: Randomized controlled trials have attested the efficacy of cognitive behavioral
therapy (CBT) in reducing psychotic symptoms. Now, studies are needed to investigate its …